SECUREWORKS CORP - A (SCWX)

US81374A1051 - Common Stock

6.27  -0.05 (-0.79%)

Fundamental Rating

2

Overall SCWX gets a fundamental rating of 2 out of 10. We evaluated SCWX against 277 industry peers in the Software industry. The financial health of SCWX is average, but there are quite some concerns on its profitability. SCWX has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year SCWX has reported negative net income.
SCWX had a negative operating cash flow in the past year.
SCWX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SCWX reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -11.88%, SCWX is in line with its industry, outperforming 42.03% of the companies in the same industry.
SCWX's Return On Equity of -17.18% is in line compared to the rest of the industry. SCWX outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -11.88%
ROE -17.18%
ROIC N/A
ROA(3y)-9.84%
ROA(5y)-6.93%
ROE(3y)-14.61%
ROE(5y)-10.37%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of SCWX (59.51%) is worse than 60.14% of its industry peers.
In the last couple of years the Gross Margin of SCWX has grown nicely.
The Profit Margin and Operating Margin are not available for SCWX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.54%
GM growth 5Y2.52%

4

2. Health

2.1 Basic Checks

SCWX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SCWX has been increased compared to 1 year ago.
Compared to 5 years ago, SCWX has more shares outstanding
There is no outstanding debt for SCWX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SCWX has an Altman-Z score of 0.54. This is a bad value and indicates that SCWX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SCWX (0.54) is worse than 68.48% of its industry peers.
SCWX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACCN/A
WACC9.91%

2.3 Liquidity

SCWX has a Current Ratio of 0.68. This is a bad value and indicates that SCWX is not financially healthy enough and could expect problems in meeting its short term obligations.
SCWX has a Current ratio of 0.68. This is amonst the worse of the industry: SCWX underperforms 89.49% of its industry peers.
SCWX has a Quick Ratio of 0.68. This is a bad value and indicates that SCWX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.68, SCWX is not doing good in the industry: 88.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.00% over the past year.
SCWX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.04%.
The Revenue has been decreasing by -6.74% on average over the past years.
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q147.06%
Revenue 1Y (TTM)-21.04%
Revenue growth 3Y-13.28%
Revenue growth 5Y-6.74%
Revenue growth Q2Q-22.68%

3.2 Future

The Earnings Per Share is expected to grow by 43.80% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -0.69% on average over the next years.
EPS Next Y113.21%
EPS Next 2Y57.74%
EPS Next 3Y43.8%
EPS Next 5YN/A
Revenue Next Year-9.3%
Revenue Next 2Y-2.83%
Revenue Next 3Y-0.69%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SCWX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 215.69, SCWX can be considered very expensive at the moment.
SCWX's Price/Forward Earnings ratio is in line with the industry average.
SCWX is valuated expensively when we compare the Price/Forward Earnings ratio to 20.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 215.69

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SCWX does not grow enough to justify the current Price/Earnings ratio.
SCWX's earnings are expected to grow with 43.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.74%
EPS Next 3Y43.8%

0

5. Dividend

5.1 Amount

No dividends for SCWX!.
Industry RankSector Rank
Dividend Yield N/A

SECUREWORKS CORP - A

NASDAQ:SCWX (5/17/2024, 7:25:32 PM)

6.27

-0.05 (-0.79%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap553.58M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 215.69
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.88%
ROE -17.18%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 59.51%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y113.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-21.04%
Revenue growth 3Y-13.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y